Literature DB >> 21664629

Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines.

Michael J Haas1, Abdul-Razzak Alamir, Senan Sultan, Joe M Chehade, Norman C N Wong, Arshag D Mooradian.   

Abstract

The objective was to test the effect of nicotinic acid on apolipoprotein A-I (apo A-I) gene expression in hepatic (HepG2) and intestinal (Caco-2) cell lines. HepG2 and Caco-2 cells were treated with 0.1, 0.3, 1.0, 3.0, and 10 mmol/L of nicotinic acid; and apo A-I concentrations in conditioned media were measured with Western blots. Relative apo A-I messenger RNA (mRNA) levels, normalized to glyceraldehyde-3-phosphate dehydrogenase mRNA, were measured with quantitative real-time polymerase chain reaction method. The nicotinic acid response element in the apo A-I promoter was identified using a series of apo A-I reporter plasmids containing deletion constructs of the promoter. In other experiments, HepG2 cells were also transfected with the apo A-I reporter plasmid and the hepatocyte nuclear factors 3α and β expression plasmids. The apo A-I levels in conditioned media from HepG2 cells, apo A-I mRNA levels, and apo A-I promoter activity increased significantly following treatment with 1.0, 3.0, and 10 mmol/L nicotinic acid. Nicotinic acid-induced promoter activity required a region of the apo A-I gene located between -170 and -186 base pairs. Exogenous overexpression of the hepatocyte nuclear factors 3α and β had no additive effect on apo A-I promoter. Apolipoprotein A-I concentrations in conditioned media and the apo A-I promoter activity were also significantly increased in Caco-2 intestinal cells. Nicotinic acid may increase apo A-I protein synthesis in the liver and small intestine. Induction of apo A-I gene by nicotinic acid requires a nicotinic acid responsive element in the apo A-I promoter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664629     DOI: 10.1016/j.metabol.2011.05.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Targeting high-density lipoproteins: increasing de novo production versus decreasing clearance.

Authors:  Arshag D Mooradian; Michael J Haas
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

Review 2.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

3.  Leucine-nicotinic acid synergy stimulates AMPK/Sirt1 signaling and regulates lipid metabolism and lifespan in Caenorhabditis elegans, and hyperlipidemia and atherosclerosis in mice.

Authors:  Antje Bruckbauer; Jheelam Banerjee; Quiang Cao; Xin Cui; Jia Jing; Lin Zha; Fenfen Li; Bingzhong Xue; Hang Shi; Michael B Zemel
Journal:  Am J Cardiovasc Dis       Date:  2017-04-15

Review 4.  Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2022-07-21       Impact factor: 11.431

5.  Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell line.

Authors:  Abbas Mohammadi; Ahmad Gholamhoseinian Najar; Amirhosein Khoshi
Journal:  Adv Biomed Res       Date:  2014-01-09

6.  Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells.

Authors:  Yuli Wang; Matthew DiSalvo; Dulan B Gunasekara; Johanna Dutton; Angela Proctor; Michael S Lebhar; Ian A Williamson; Jennifer Speer; Riley L Howard; Nicole M Smiddy; Scott J Bultman; Christopher E Sims; Scott T Magness; Nancy L Allbritton
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.